1. The ability of miRNAs to induce mesenchymal-to-epithelial transition (MET) in cancer cells is highly dependent upon genetic background
   Mengnan Zhang et al, 2020, Cancer Letters CrossRef
2. Inhibition of microRNA‑492 attenuates cell proliferation and invasion in retinoblastoma via directly targeting LATS2
   Zhiqun Sun et al, 2018, Molecular Medicine Reports CrossRef
3. miRNA signatures in childhood sarcomas and their clinical implications
   G. M. Viera et al, 2019, Clinical and Translational Oncology CrossRef
4. Association between miR-492 rs2289030 G>C and susceptibility to Hirschsprung disease in southern Chinese children
   Yi Zheng et al, 2020, Journal of International Medical Research CrossRef
5. A novel pyroptosis-related indicator of immune infiltration features and prognosis in breast cancer
   Cheng Wang et al, 2022, Frontiers in Oncology CrossRef
6. Human p21-activated kinase 5 (PAK5) expression and potential mechanisms in relevant cancers: Basic and clinical perspectives for molecular cancer therapeutics
   Yu-kun Li et al, 2020, Life Sciences CrossRef
7. p21-Activated kinases as promising therapeutic targets in hematological malignancies
   Andrew Wu et al, 2022, Leukemia CrossRef
8. Current status and future perspectives in dysregulated miR-492
   Jinze Shen et al, 2023, Gene CrossRef
9. miR-340 alleviates chemoresistance of osteosarcoma cells by targeting ZEB1
   Haibin Yan et al, 2018, Anti-Cancer Drugs CrossRef
10. Inhibiting p21-activated kinase (PAK7) enhances radiosensitivity in hepatocellular carcinoma
    Y-F Gu et al, 2021, Human & Experimental Toxicology CrossRef
11. Targeting AXL in mesothelioma: From functional characterization to clinical implication
    Kinjal Bhadresha et al, 2023, Critical Reviews in Oncology/Hematology CrossRef